Literature DB >> 33007091

The impact of depression and anxiety in prognosis of patients undergoing myocardial perfusion imaging with 99mTc tetrofosmin SPECT for evaluation of possible myocardial ischemia.

Andreas Fotopoulos1, Petros Petrikis2, Ioannis Iakovou3, Athanasios Papadopoulos4, Konstantinos Sakelariou5, Evangelia Gkika5, Lampros Lakkas6, Christos Touzios5, Konstantinos Pappas6, Antonios Klaroudas5, Argyrios Doumas3, Chrissa Sioka5.   

Abstract

BACKGROUND: The goal of this study was to evaluate the prevalence of depression and anxiety in patients subjected to myocardial perfusion imaging (MPI) with 99mTc tetrofosmin stress-rest single-photon emission computer tomography (SPECT), and their impact on their cardiological events or disease.
MATERIAL AND METHODS: Patients referred to the Nuclear Medicine Department for 99mTc tetrofosmin myocardial MPI-SPECT were asked to fulfill the Zung Self-Rating Depression Scale (ZDS) and Hamilton anxiety questionnaire (HAQ). Among 213 patients who completed the ZDS and HAQ, 80 patients (59 males and 21 females) were selected for this study because they had no known psychological disease, other disease that could influence psychological status, or use of narcotic drugs. Collected data from MPI and psychological status were subsequently analyzed.
RESULTS: Among all 80 patients, 52 patients (65%) had abnormal MPI of whom 28/52 (53.8%) exhibited either depression, anxiety or both, and 28 (35%) patients had normal MPI of whom 10/28 (35.7%) had abnormal psychological status. The higher number of patients with abnormal psychological status in association with abnormal MPI was noted predominantly in patients with previously established coronary artery disease. A correlation was also noted between obesity, cardiac heredity and depression or anxiety in patients with abnormal MPI.
CONCLUSIONS: Patients that exhibit depression, anxiety, or both, have high rates of myocardial ischemia, and thus are at risk for subsequent cardiological events.

Entities:  

Keywords:  MPI; SPECT; anxiety; depression; myocardial ischemia; myocardial perfusion imaging; psychological status

Mesh:

Substances:

Year:  2020        PMID: 33007091     DOI: 10.5603/NMR.a2020.0014

Source DB:  PubMed          Journal:  Nucl Med Rev Cent East Eur        ISSN: 1506-9680


  3 in total

1.  Authors' Reply to: To Screen or Not to Screen? At Which BMI Cut Point? Comment on "Obesity and BMI Cut Points for Associated Comorbidities: Electronic Health Record Study".

Authors:  Luke Funk; Natalie Liu
Journal:  J Med Internet Res       Date:  2022-06-29       Impact factor: 7.076

2.  To Screen or Not to Screen? At Which BMI Cut Point? Comment on "Obesity and BMI Cut Points for Associated Comorbidities: Electronic Health Record Study".

Authors:  Chrissa Sioka
Journal:  J Med Internet Res       Date:  2022-06-29       Impact factor: 7.076

3.  Body Mass Index Is Independently Associated with the Presence of Ischemia in Myocardial Perfusion Imaging.

Authors:  Chrissa Sioka; Paraskevi Zotou; Michail I Papafaklis; Aris Bechlioulis; Konstantinos Sakellariou; Aidonis Rammos; Evangelia Gkika; Lampros Lakkas; Sotiria Alexiou; Pavlos Kekiopoulos; Katerina K Naka; Christos Katsouras
Journal:  Medicina (Kaunas)       Date:  2022-07-25       Impact factor: 2.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.